Zelira Therapeutics's total assets for Q4 2024 were AU$5.18M, an increase of 60.51% from the previous quarter. AU:ZLD total liabilities were AU$9.36M for the fiscal quarter, a 79.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.